Evidence map›Paper›PMID 33771829›Full record

ArticleBMJ open2021

Association between insulin resistance and post-ischaemic stroke outcome in patients without diabetes: protocol for a systematic review and meta-analysis.

Jeremiah Hadwen, Woojin Kim, Brian Dewar, Tim Ramsay, Alexandra Davis, Dar Dowlatshahi, Michel Shamy

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jeremiah HadwenNeurology, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada jhadw013@uottawa.ca.ORCID http://orcid.org/0000-0002-7519-8272
Woojin KimNeurology, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada.
Brian DewarNeurology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Tim RamsayClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID http://orcid.org/0000-0001-8478-8170
Alexandra DavisRoyal Ottawa Mental Health Centre, Ottawa, Ontario, Canada.
Dar DowlatshahiNeurology, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada.
Michel ShamyNeurology, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada.
University of Ottawa · CAOttawa Hospital · CARoyal Ottawa Mental Health Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInsulin resistance is an independent risk factor for atherosclerosis, coronary artery disease and ischaemic stroke. Currently, insulin resistance is not usually included in post-stroke risk stratification. This systematic review and meta-analysis intends to determine if available scientific knowledge supports an association between insulin resistance and post-stroke outcomes in patients without diabetes. METHODS AND ANALYSIS: The authors will conduct a literature search in Medline, Embase, Web of Science and Cochrane Central. The review will include studies that assess the association between elevated insulin homeostasis model of insulin resistance (HOMA-IR) and post-stroke outcome (functional outcome and recurrent stroke). The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) reporting guidelines will be used. The primary outcome will be post-stroke functional outcome (Modified Rankin Scale), and the secondary outcome will be recurrent ischaemic stroke. Comparison of outcome will be made between highest and lowest HOMA-IR range (as defined in each article included in this systematic review). Risk of bias will be assessed qualitatively. Meta-analysis will be performed if sufficient homogeneity exists between studies. Heterogeneity of outcomes will be assessed by ETHICS AND DISSEMINATION: No human or animal subjects or samples were/will be used. The results will be published in a peer-reviewed journal, and will be disseminated at local and international neurology conferences. PROSPERO REGISTRATION NUMBER: CRD42020173608.

Indexed as

Brain IschemiaDiabetes MellitusInsulin ResistanceIschemic StrokeStrokeHumansMeta-Analysis as TopicResearch DesignSystematic Reviews as Topicdiabetes & endocrinologyneurologystroke

Identifiers

PMID33771829
PMCPMC8006852
OpenAlexW3136452631

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.